Event

Richard Casaburi

MD, PhD
Harbor-UCLA Medical Center;LA BioMed at Harbor-UCLA Medical Center;Los Angeles BioMed Rsch Inst;Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center;Rehabilitation Clinical Trials C

William W. Stringer

MD
Habor-UCLA Medical Center;Harbor UCLA Medical Center;Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center;Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Inst

Harry B. Rossiter

PhD
LA BioMed at Harbor-UCLA Medical Center;Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center;Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harb

Janos Porszasz

MD, PhD
Los Angeles Biomedical Research Inst;Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center;Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor

Asli Gorek Dilektasli

MD
Uludag University Faculty of Medicine

Youngju Pak

PhD
UCLA Clinical and Translational Science Institute, Los Angeles Biomedical Research Institute at Harb

James E. Hansen

MD
Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor UCLA Medi

A New Bronchodilator Response Grading Strategy Based on Distribution of FEV1 Increase Identifies Clinically Distinct Patient Groups in the COPDGene Cohort